Journal
JOURNAL OF CYSTIC FIBROSIS
Volume 16, Issue 5, Pages 565-572Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jcf.2017.04.015
Keywords
Cystic fibrosis; Lung surfactant; Cholesterol; oxidative stress; Surface tension; Phospholipids; Free fatty acids; Inflammation; Infection; Genotypes
Categories
Funding
- TAO Foundation [RT753688]
- Alberta Innovates Health Solutions (AIRS) [20150980]
- Calgary Laboratory Services (CLS) [73-2144]
- Alberta Lung Association
Ask authors/readers for more resources
Background: Airway surfactant is impaired in cystic fibrosis (CF) and associated with declines in pulmonary function. We hypothesized that surfactant dysfunction in CF is due to an excess of cholesterol with an interaction with oxidation. Methods: Surfactant was extracted from bronchial lavage fluid from children with CF and surface tension, and lipid content, inflammatory cells and microbial flora were determined. Dysfunctional surfactant samples were re-tested with a lipid-sequesteringagent, methyl-beta-cyclodextrin (M beta CD). Results: CF surfactant samples were unable to sustain a normal low surface tension. M beta CD restored surfactant function in a majority of samples.Mechanistic studies showed that the dysfunction was due to a combination of elevated cholesterol and an interaction with oxidized phospholipids and their pro-inflammatory hydrolysis products. Conclusion: We confirm that CF patients have impaired airway surfactant function which could be restored with m beta cD. These findings have implications for improving lung function and mitigating inflammation in patients with CF. (C) 2017 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available